Nuvectis Pharma, Inc. Common Stock

NVCT · Pharmaceutical Preparations · $716.8M
Powering up
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read

Nuvectis Pharma, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 98, and it sits in Pharmaceutical Preparations.

Peers
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

Flagged by the market sweep
GappedTape · 2026-09-16
-6.1%
GappedTape · 2026-09-12
+6.7%

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news

No headlines for this company in the last couple of weeks.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Nuvectis Pharma, Inc. Common Stock (NVCT) — The Tape